Polypox A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 1.8% 2.5% 2.3% 2.3%  
Credit score (0-100)  0 70 60 64 60  
Credit rating  N/A A BBB BBB BBB  
Credit limit (kDKK)  0.0 0.6 0.0 0.0 0.1  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 790 1,841 791 1,288  
EBITDA  0.0 790 1,841 791 1,288  
EBIT  0.0 685 1,702 673 1,162  
Pre-tax profit (PTP)  0.0 671.7 1,677.2 637.9 1,153.9  
Net earnings  0.0 524.0 1,308.2 494.0 899.4  
Pre-tax profit without non-rec. items  0.0 672 1,677 638 1,154  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 561 421 283 220  
Shareholders equity total  0.0 924 2,006 2,276 1,875  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 1,827 4,140 3,994 3,261  

Net Debt  0.0 -555 -605 -592 -399  
 
See the entire balance sheet

Volume 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 790 1,841 791 1,288  
Gross profit growth  0.0% 0.0% 133.2% -57.0% 62.8%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 1,827 4,140 3,994 3,261  
Balance sheet change%  0.0% 0.0% 126.6% -3.5% -18.3%  
Added value  0.0 789.5 1,841.4 812.6 1,287.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 456 -279 -256 -188  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 1.0 2.0 3.0 4.0  

Profitability 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 86.7% 92.4% 85.1% 90.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 37.5% 57.0% 16.6% 32.1%  
ROI %  0.0% 51.5% 87.2% 25.8% 50.0%  
ROE %  0.0% 56.7% 89.3% 23.1% 43.3%  

Solidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 50.6% 48.5% 57.0% 57.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% -70.3% -32.8% -74.8% -31.0%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 2.3 2.2 2.5 2.1  
Current Ratio  0.0 2.5 2.4 2.7 2.4  
Cash and cash equivalent  0.0 555.4 604.6 592.0 398.7  

Capital use efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 769.5 2,150.2 2,357.8 1,789.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0